Our Team

Our Team

WILLIAM B. SMITH, MD, FACC, CPI, Chief Executive Officer

Dr. William Smith is the Founder, President, and Principal Investigator of VRG and NOCCR, the AMR centers in Knoxville, TN and New Orleans, LA. He is also one of the original founders of AMR. Dr. Smith is board certified in Internal Medicine, Critical Care Medicine, Nephrology, and Cardiology. He has been involved in more than 1,700 clinical trials over the past 35 years. He is a frequent lecturer and author and publishes extensively.

SCOTT STONE, Chief Financial Officer, CPA
For nearly two decades, Mr. Stone has served in senior executive roles, primarily as a Chief Financial Officer or Chief Operating Officer. A Certified Public Accountant, he has broad and deep experience working with both public and private companies across an array of industries, including technology, healthcare, telecommunications and manufacturing. Other experience includes capital strategies. Scott has worked with the Fortune 50, private equity-backed companies and closely held, lower middle market enterprises. His other experience includes capital formation, strategic planning, organizational development, and exit advisory.

Jesse Hoffman has over 15 years of clinical research industry experience, working at a leading CRO and site organization.  In the CRO space, he has served in a variety of leadership and business development roles, joining PharmaNet in 2007, which through several M&A transactions became Syneos Health, a top global CRO.  Before joining PharmaNet, he served as President at Advanced Clinical Research, a previous member of AMR, with research centers in Utah and Idaho.

TERRY L. POLING, MD, DABFM, FAAFP, CPI, Regional Vice President

Terry serves as Regional Vice President for the Western Region.  He is board certified in Family Medicine and started his private practice after serving in the Air Force as a flight surgeon. He began conducting clinical research trials in 1991. He is an Associate Clinical Professor at the University of Kansas School of Medicine. Dr. Poling founded Heartland Research Associates in 1994 with five dedicated research centers located in Wichita, KS and the surrounding area and has been involved in over 1,392 trials. Heartland Research Associates joined AMR in 2000.

Debbie Dyer, RN, BSN, regional vice president

Debbie currently serves as the  Regional Vice President of AMR’s Eastern Region. She is the co-founder of AMR-Lexington, previously Central Kentucky Research Associates (CKRA) . In 1991, CKRA was launched by Debbie she and her business partner, the late Jacquie Smith. Together they built a responsive and respected organization that consistently delivers results by aligning technology, goals and ongoing improvements to service and performance to the clinical trial industry for over 25 years. Debbie holds a BSN from Eastern Kentucky University College of Allied Health and Nursing , and holds an active nursing license from the state of Kentucky. With over 25 years experience in clinical trials, she is a well respected figure in the industry. Previously, Debbie was recognized as Small Business Person of the Year for the State of Kentucky by the U.S. Small Business Administration. 

JEFFREY B. ROSEN, MD, DABFM, FAAFP, Chief Medical Officer

Dr. Jeffrey Rosen is the Medical Director of Clinical Research of South Florida. He has been conducting clinical research for 34 years and has been involved in more than 800 clinical trials. Dr. Rosen is a founding member of AMR and is on the Leadership Council for the Society for Clinical Research Sites. He has been a speaker at many research conferences and for several pharmaceutical companies.

Brenda Atchison is AMR’s Vice President – Strategic Partnerships.  She holds a Bachelor’s degree in Clinical Microbiology and Chemistry from the University of Tennessee prior to accepting a clinical microbiology position with the Tennessee State Department of Public Health and Environmental Services. She also served as a clinical scientist with supervisory responsibility over the cellular immunology division in a national cancer research center prior to joining the Institute of Clinical Pharmacology (Covance) in 1989. At Covance, she served as Senior Global Director of Project Feasibility and Investigative Site Services until joining AMR in 2000 as Executive Director of Business Development. In her current role, she serves as liaison to AMR’s many top CRO and Pharmaceutical clients.